Mixture Modeling with NONMEM V

Pharmacometrics: The Science of Quantitative Pharmacology

Volumn , Issue , 2006, Pages 723-757

  Frame, Bill ^a  

^a NONE   (United States)

Author keywords

Biological mixtures; Dynamic mixtures; FO; FOCE; FOCE with interaction; FORTRAN coding; Hypothesis testing; Leptokurtosis; Mixture modeling; Multiple mixtures; NONMEM; Simulation; Skewness; Sub model parameterization; Subpopulation

Indexed keywords

EID: 77149124597     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470087978.ch28     Document Type: Chapter

References (34)

1. E. Peretti, G. Karlaganis, and G. H. Lauterburg, Acetylation of acetylhydrazine, the toxic metabolite of isoniazid in humans. Inhibition by concomitant administration of isoniazid. J Pharmacol Exp Ther 243:686 (1987).
2. W. W. Weber and D. W. Hein, N-acetylation pharmacogenetics. Pharmacol Rev 37:25 (1985).
3. F. J. Chaves, V. Giner, D. Corella, J. Pascual, P. Marin, M. E. Armengod, and J. Redon, Body weight changes and the A-6G polymorphism of the angiotensinogen gene. Int J Obes Relat Metab Disord 26:1173-1178 (2002).
4. G. P. Reynolds, Z. J. Zhang, and X. B. Zhang, Association of antipsychotic drug induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359:2086-2087 (2002).
5. H. Y. Lane, Y. C. Chang, Y. C. Cheng, G. C. Liu, X. R. Lin, and W. H. Chang, Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia. J Clin Psychiatry 64:316-320 (2003).
6. M. Masellis, V. Basile, H. Y. Meltzer, L. A. Lieberman, S. Sevy, F. M. Macciardi, P. Cola, A. Howard, F. Badri, M. M. Nothen, W. Kalow, and J. L. Kennedy, Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 19:123-132 (1998).
7. J. Marc, J. Prezelj, R. Komel, and A. Kocijancic, VDR genotype and response to etidronate therapy in late postmenopausal women. Osteoporos Int 10:303-306 (1999).
8. J. A. Millar, K. Thai, and J. W. Scholey, Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 56:2173-2180 (1999).
9. P. Dalen, M. L. Dahl, M. L. B. Ruiz, J. Nordin, and L. Bertilsson, 10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes. Clin Pharmacol Ther 63:444-452 (1998).
10. F. Saarikoski, K. Sata, J. Husgafvel-Pursianen, O. Haukka, J. Impivaara, H. Jarvisalo, H. Vainio, and A. Hirvonen, CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behavior. Pharmacogenetics 10:5-10 (2000)
11. P. Dalen, C. Frengall, M. L. Dahl, and F. Sjoqvist, Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine. Ther Drug Monit 19:543-544 (1997).
12. J. A. Kuivenhoven, J. W. Jukema, A. H. Zwinderman, P. Knijff, R. McPherson, A. V. G. Bruschke, K. I. Lie, and J. J. P. Kastelein, The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med 338:86-93 (1998).
13. D. K. Kim, S. W. Lim, S. Lee, S. E. Sohn, S. Kim, C. G. Hahn, and B. J. Carroll, Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11:215-219 (2000).
14. A. Odani, Y. Hashimoto, Y. Otsuki, Y. Uwai, H. Hattori, K. Furusho, and K. Inui, Genetic polymorphisms of the CYP2C sub-family and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy. Clin Pharmacol Ther 62:287-292. (1997).
15. K. Mamiya, I. Ieiri, J. Shimamoto, E. Yukawa, J. Imai, H. Ninomiya, H. Yamada, K. Otsubo, S. Higuchi, and N. Tashiro, The effect of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics. Epilepsia 39:1317-1323 (1998).
16. S. L. Beal and L. B. Sheiner, NONMEM Users Guides. NONMEM Project Group, University of California, San Francisco, 1999.
17. K. Pearson, Contributions to the mathematical theory of evolution. Phil Trans R Soc Lond A 185:71-110 (1894).
18. J. P. Harding, The use of probability paper for the graphical analysis of polymodal frequency distributions. J Marine Biol Assoc UK 28:141-153 (1948).
19. C. R. Rao, The utilization of multiple measurements in problems of biological classification. J R Stat Soc B 10:159-203 (1948).
20. E. I. Ette and T. M. Ludden, Population pharmacokinetic modeling: the importance of informative graphics. Pharm Res 12:1845-1855 (1995).
21. B. Facca, B. Frame, and S. Triesenberg, Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill patients. Antimicrob Agents Chemother 42:1783-1787 (1998).
22. R. Miller, B. Frame, B. W. Corrigan, P. Burger, H. Bockbrader, H. Garofolo, and R. Lalonde, Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures. Clin Pharmacol Ther 73:491-505. (2003).
23. R. Hussein, B. G. Charles, R. G. Morris, and R. L. Rasiah, Population pharmacokinetics of perhexiline from very sparse, routine monitoring data. Ther Drug Monit 23:636-643 (2001).
24. T. Shiiki, Y. Hashimoto, and K. Inui, Simulation for population pharmacodynamic analysis of dose-ranging trials: usefulness of the mixture model analysis for detecting nonresponders. Pharm Res 19:909-913 (2002).
25. P. H. Zingmark, M. Ekblom, T. Odergren, T. Ashwood, P. Lyden, M. Karlsson, and N. Jonsson, Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. Br J Clin Pharmacol 56:173-183 (2003).
26. R. D. Gibbons, E. Dorus, D. G. Ostrow, G. N. Pandey, J. M. Davis, and D. L. Levy, Mixture distributions in psychiatric research. Biol Psychiatry 19:935-961 (1984).
27. G. J. McLachlan and K. E. Basford, Mixture Models-Inference and Applications to Clustering. Marcel Dekker, New York, 1988.
28. D. M. Titterington, A. F. M. Smith, and U. E. Makov, Statistical Analysis of Finite Mixture Distributions. Wiley, Hoboken, NJ, 1985.
29. B. Frame, R. Miller, and R. Lalonde, Evaluation of mixture modeling with count data using NONMEM. J Pharmacokinet Pharmacodyn 30:167-183 (2003).
30. R. I. Jennrich, Asymptotic properties of non-linear least squares estimators. Ann Math Stat 40:633-643 (1969).
31. J. H. Wolfe, A Monte Carlo study of the sampling distribution of the likelihood ratio for mixtures of multinomial distributions. Technical Bulletin STB 72-2. U.S. Naval Personnel and Training Research Laboratory, San Diego, 1971.
32. T. R. Belin and D. B. Rubin, The analysis of repeated-measures data on schizophrenic reaction times using mixture models. Stat Med 14:747-768 (1995).
33. P. O. Gisleskog, M. O. Karlsson, and S. L. Beal, Use of prior information to stabilize a population data analysis. J Pharmacokinet Pharmacodyn 29:473-505 (2002).
34. Y. Yano, S. L. Beal, and L. B. Sheiner, Evaluating pharmacokinetic/pharmacodynamic models using the posterior predicitive check. J Pharmacokinet Pharmacodyn 28:171-192 (2001).